Shijiazhuang Yiling Pharmaceutical Co., Ltd.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Mar 2026 is 24.28% vs 7.42% in Dec 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Mar 2026 is 43.32% vs -13.97% in Dec 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Dec'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "2,439.80",
          "val2": "1,963.10",
          "chgp": "24.28%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "488.70",
          "val2": "554.30",
          "chgp": "-11.83%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.40",
          "val2": "0.30",
          "chgp": "33.33%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.80",
          "val2": "3.90",
          "chgp": "-79.49%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "408.60",
          "val2": "285.10",
          "chgp": "43.32%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "200.30%",
          "val2": "198.90%",
          "chgp": "0.14%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is 20.20% vs -36.99% in Dec 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is 274.57% vs -154.62% in Dec 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "7,762.20",
          "val2": "6,457.50",
          "chgp": "20.20%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "1,951.70",
          "val2": "-391.20",
          "chgp": "598.90%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "3.20",
          "val2": "41.20",
          "chgp": "-92.23%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-3.60",
          "val2": "-6.30",
          "chgp": "42.86%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "1,281.70",
          "val2": "-734.20",
          "chgp": "274.57%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "197.90%",
          "val2": "-130.10%",
          "chgp": "32.80%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ

Mar'26

Dec'25

Change(%)

Net Sales

2,439.80

1,963.10

24.28%

Operating Profit (PBDIT) excl Other Income

488.70

554.30

-11.83%

Interest

0.40

0.30

33.33%

Exceptional Items

0.80

3.90

-79.49%

Consolidate Net Profit

408.60

285.10

43.32%

Operating Profit Margin (Excl OI)

200.30%

198.90%

0.14%

USD in Million.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Mar 2026 is 24.28% vs 7.42% in Dec 2025

Consolidated Net Profit

QoQ Growth in quarter ended Mar 2026 is 43.32% vs -13.97% in Dec 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'25

Dec'25

Dec'24

Change(%)

Net Sales

7,762.20

6,457.50

20.20%

Operating Profit (PBDIT) excl Other Income

1,951.70

-391.20

598.90%

Interest

3.20

41.20

-92.23%

Exceptional Items

-3.60

-6.30

42.86%

Consolidate Net Profit

1,281.70

-734.20

274.57%

Operating Profit Margin (Excl OI)

197.90%

-130.10%

32.80%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2025 is 20.20% vs -36.99% in Dec 2024

Consolidated Net Profit

YoY Growth in year ended Dec 2025 is 274.57% vs -154.62% in Dec 2024

All Annual Results